Study of Facilitator-led Strategies to Improve HPV Vaccination Recommendations and Rates Among Latino Adolescents at Federally Qualified Health Centers

What this Trial Is About

This research aims to understand how different factors at the provider and clinic levels affect the success of strategies led by facilitators to increase healthcare providers recommendations and vaccination rates for Human Papillomavirus HPV among Latinoa adolescents. The study focuses on nine Federally Qualified Health Centers FQHCs with a high Latino adolescent population, evaluating the sustainability and impact of these facilitator-driven strategies over time. The study involves a facilitator who works with healthcare providers and immunization navigators at each clinic using four key strategies provider education modules, development of a clinical practice plan, training of immunization navigators to carry out the plan, and providing ongoing technical assistance with assessment and feedback. Clinics are randomized into three groups with staggered timing for control and intervention phases lasting from 15 to 27 months for control and 18 to 30 months for intervention periods. Participants include providers, staff, and parents of adolescent patients at each clinic. Researchers will measure HPV vaccination rates, such as the percentage of adolescents receiving the first and second doses before specific birthday milestones, along with uptake of other vaccines like Tdap and MenACWY. Data will be collected from baseline through about 60 months to assess the effect of the implementation strategies, with regular monitoring and feedback to support adherence and sustainability.

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents